MDXH
MDxHealth S.A.NASDAQHealthcare$2.16-5.09%ClosedMarket Cap: $110.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-8.48
P/S
0.98
EV/EBITDA
-27.67
DCF Value
$-61.32
FCF Yield
-11.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
59.7%
Operating Margin
-14.3%
Net Margin
-31.1%
ROE
516.6%
ROA
-22.7%
ROIC
-14.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $54.7M | 53.6% | $-11.6M | $-18.8M | $-0.37 | — |
| FY 2025 | $107.9M | 59.7% | $-15.4M | $-33.5M | $-0.67 | — |
| Q2 2025 | $53.2M | 66.0% | $-3.8M | $-14.7M | $-0.30 | — |
| Q4 2024 | $48.1M | 62.0% | $-10.7M | $-18.0M | $-0.38 | — |
| FY 2024 | $90.0M | 61.2% | $-24.7M | $-38.1M | $-1.16 | — |
| Q2 2024 | $42.0M | 60.4% | $-14.0M | $-20.0M | $-0.73 | — |
| Q4 2023 | $38.7M | 65.1% | $-10.9M | $-20.8M | $-0.76 | — |
| FY 2023 | $70.2M | 62.6% | $-27.3M | $-43.1M | $-1.66 | — |
| Q2 2023 | $31.4M | 59.5% | $-16.5M | $-22.3M | $-1.02 | — |
| Q4 2022 | $24.0M | 55.9% | $-20.9M | $-25.9M | $-2.13 | — |
| FY 2022 | $37.1M | 51.9% | $-37.9M | $-44.0M | $-2.78 | — |
| Q2 2022 | $13.0M | 44.4% | $-17.0M | $-18.1M | $-1.52 | — |